CA3188531A1 - Compositions topiques, procede de fabrication a grande echelle et methode d'utilisation - Google Patents
Compositions topiques, procede de fabrication a grande echelle et methode d'utilisationInfo
- Publication number
- CA3188531A1 CA3188531A1 CA3188531A CA3188531A CA3188531A1 CA 3188531 A1 CA3188531 A1 CA 3188531A1 CA 3188531 A CA3188531 A CA 3188531A CA 3188531 A CA3188531 A CA 3188531A CA 3188531 A1 CA3188531 A1 CA 3188531A1
- Authority
- CA
- Canada
- Prior art keywords
- oil
- composition
- amount
- skin
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/577—Malvaceae (Mallow family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
L'invention concerne des compositions pour le traitement de certaines maladies orphelines et d'ulcères de la muqueuse buccale, dont beaucoup présentent des similitudes en ce qui concerne leurs activités anti-inflammatoire et anti-oxydante, mais également de multiples différences pour ce qui est de leurs capacités observées qui peuvent être combinées pour enrayer la pathophysiologie en cours sous-jacente. Les maladies orphelines d'intérêt sont la maladie de Dupuytren, la maladie de La Peyronie, la sclérodermie, le phénomène de Raynaud (ou de Renaud), l'ulcération de la muqueuse buccale induite par la chimiothérapie/les rayons, et les ulcères aphteux; ainsi que des problèmes de peau plus fréquents de lésions cutanées dues à des coupures, des abrasions et des brûlures; les modifications de la peau liées au vieillissement et les mycoses d'ongles des orteils. Ceux-ci peuvent être traités avec les compositions décrites avec la combinaison et la modification appropriées des ingrédients y compris l'alpha-pinène, une préparation d'aloe vera, et une préparation de beurre de karité. L'invention concerne également un procédé de préparation de tels ingrédients dans une émulsion eau-dans-huile.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2020/034422 WO2021236108A1 (fr) | 2020-05-22 | 2020-05-22 | Compositions topiques, procédé de fabrication à grande échelle et méthode d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3188531A1 true CA3188531A1 (fr) | 2021-11-25 |
Family
ID=78708009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3188531A Pending CA3188531A1 (fr) | 2020-05-22 | 2020-05-22 | Compositions topiques, procede de fabrication a grande echelle et methode d'utilisation |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4153321A4 (fr) |
| CA (1) | CA3188531A1 (fr) |
| WO (1) | WO2021236108A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024073013A1 (fr) * | 2022-09-28 | 2024-04-04 | Eresina, Llc | Traitement combiné de maladies fibrotiques dermiques et transdermiques, de troubles, et de la douleur et de l'inflammation associées |
| WO2024073011A1 (fr) * | 2022-09-28 | 2024-04-04 | Eresina, Llc | Compositions topiques et procédés pour le traitement de maladies fibrotiques dermiques et transdermiques, de troubles et de la douleur et de l'inflammation associées |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4784842A (en) * | 1987-09-25 | 1988-11-15 | Jean London | Therapeutic composition for treatment of cuts, burns and abrasions |
| US7563461B2 (en) * | 2002-02-07 | 2009-07-21 | The Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of dermal and mucosal irritation |
| US20080038219A1 (en) * | 2006-08-07 | 2008-02-14 | Calgenex Corporation | Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof |
| KR100873946B1 (ko) * | 2007-06-11 | 2008-12-12 | 바이오스펙트럼 주식회사 | 알파-피넨을 유효성분으로 포함하는 피부주름 개선제 |
| DK2648809T3 (da) * | 2010-12-09 | 2019-07-15 | Y&B Mothers Choice Ltd | Naturlige formuleringer |
| US9095607B2 (en) * | 2013-12-31 | 2015-08-04 | Antonino Cavallaro | Gel for topical application of clove essential oil with broad spectrum anti-inflammatory action and method of preparing same |
| US20160045412A1 (en) * | 2014-08-18 | 2016-02-18 | Matthew P. Davies | Antifungal, antibacterial topical composition for the prevention and treatment of various skin conditions including diaper rash |
| WO2019104249A1 (fr) * | 2017-11-22 | 2019-05-31 | Progeneron | Compositions topiques, leur procédé de fabrication et leur procédé d'utilisation |
-
2020
- 2020-05-22 WO PCT/US2020/034422 patent/WO2021236108A1/fr not_active Ceased
- 2020-05-22 EP EP20936216.9A patent/EP4153321A4/fr active Pending
- 2020-05-22 CA CA3188531A patent/CA3188531A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021236108A1 (fr) | 2021-11-25 |
| EP4153321A1 (fr) | 2023-03-29 |
| EP4153321A4 (fr) | 2024-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11564963B2 (en) | Topical compositions, process of large-scale manufacture, and method of use | |
| US20190151232A1 (en) | Topical Compositions, Process of Manufacture and Method of Use | |
| US20060029627A1 (en) | Antipruritic composition and wound-healing-promoting composition | |
| US20130095196A1 (en) | Blended oil skin moisturizer and skin repairer | |
| US9579357B1 (en) | Therapeutic compositions | |
| KR20210043318A (ko) | 천연추출복합물을 함유하는 피부 크림 화장용 조성물 | |
| MX2012001611A (es) | Medicamento topico para el tratamiento de psoriasis. | |
| CA3188531A1 (fr) | Compositions topiques, procede de fabrication a grande echelle et methode d'utilisation | |
| US8383166B2 (en) | Stable hydrophobic topical herbal formulationn | |
| CA2627021A1 (fr) | Formulation topique de source naturelle/anesthesiant local/compose ameliorant la penetration utile pour le traitement de la douleur, du prurit et/ou d'une inflammation cutanee | |
| US8003142B2 (en) | Therapeutic and cosmetic balsam | |
| JP2020152709A (ja) | 皮膚疾患治療剤及びその製造方法 | |
| RU2369377C1 (ru) | Фитобальзам для регенерации кожи "инсофит" | |
| JPH11322628A (ja) | 皮膚外用剤 | |
| KR100892742B1 (ko) | 여드름 치료용 피부 외용제 조성물 | |
| WO2004096119A2 (fr) | Compositions pharmaceutiques topiques, procedes de preparation de ces compositions et articles manufactures contenant ces dernieres | |
| CN115671239B (zh) | 一种抗炎消肿抑菌止痒防裂修复的冻愈膏及其制备方法 | |
| US20250302904A1 (en) | Extracts in eutectic solvent of olive oil polyphenols, compositions, uses and methods of preparation thereof | |
| WO2009020398A2 (fr) | Produit de soins de la peau | |
| Dalianis | TREATMENT OF ECZEMA AND ONYCHOMYCOSIS BY DAILY PRODUCTS:‘’OPENING THE OLD BOOKS’’ | |
| Shingala et al. | Development and Evaluation of Herbal Ointment for Skin Burn | |
| Federico et al. | Extracts in eutectic solvent of olive oil polyphenols, compositions, uses and methods of preparation thereof | |
| JP2025532950A (ja) | 皮膚および経皮線維性疾患、障害、ならびに関連する疼痛および炎症の併用処置 | |
| Riaz et al. | The bariatric improvement and toxicity of botanical oils for skin care | |
| US20160051609A1 (en) | Topical Pharmaceutical Bases for Treating Inflammatory Disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20240517 |